AbCellera Biologics Inc.
ABCL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001703057
In the last 90 days, AbCellera Biologics Inc. insiders filed 4 open-market purchases and 0 sales; 150 institutions reported holding it in 13F filings for Q2 2026, worth $908.8M in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in AbCellera Biologics Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 116
- +2 vs. Q2 2021
- Shares held
- 98.7M
- +8.14M (+9.0%) vs. Q2 2021
- Total value
- $1.98B
- −$8.58M (−0.4%) vs. Q2 2021
- New holders
- 28
- 48 more added
- Sold out
- 26
- 25 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ABCL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 150 | $908.8M |
| Q1 2026 | 138 | $434.0M |
| Q4 2025 | 144 | $370.6M |
| Q3 2025 | 141 | $524.6M |
| Q2 2025 | 128 | $370.6M |
| Q1 2025 | 129 | $280.1M |
| Q4 2024 | 146 | $333.9M |
| Q3 2024 | 139 | $274.6M |
| Q2 2024 | 148 | $338.3M |
| Q1 2024 | 154 | $547.4M |
| Q4 2023 | 143 | $681.1M |
| Q3 2023 | 138 | $551.8M |
| Q2 2023 | 170 | $809.1M |
| Q1 2023 | 183 | $980.7M |
| Q4 2022 | 203 | $1.30B |
| Q3 2022 | 190 | $1.21B |
| Q2 2022 | 162 | $1.26B |
| Q1 2022 | 130 | $1.10B |
| Q4 2021 | 124 | $1.63B |
| Q3 2021 | 116 | $1.98B |
| Q2 2021 | 114 | $1.99B |
| Q1 2021 | 86 | $2.42B |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding AbCellera Biologics Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Clough Capital Partners L P | 971,297 | $19.5M | 1.21% | +272,497+39.0% | Added |
| BlackRock Inc. | 976,587 | $19.6M | 0.00% | +79,400+8.8% | Added |
| Intellectus Partners, LLC | 1,223,429 | $24.5M | 5.94% | +16,450+1.4% | Added |
| Parametric Portfolio Associates LLC | 1,700,000 | $34.1M | 0.02% | +200,000+13.3% | Added |
| Swedbank AB | 1,805,010 | $36.2M | 0.07% | +953,860+112.1% | Added |
| Credit Suisse AG | 2,802,411 | $56.2M | 0.05% | +166,638+6.3% | Added |
| Baillie Gifford & Co | 3,240,543 | $64.9M | 0.03% | +515,346+18.9% | Added |
| Founders Fund VII Management, LLC | 3,773,530 | $75.6M | 86.10% | 00.0% | Unchanged |
| Guardian Capital Advisors LP | 3,836,414 | $76.8M | 7.97% | −139,580−3.5% | Reduced |
| Harvard Management Co Inc | 4,105,095 | $82.3M | 4.82% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 4,180,768 | $83.8M | 0.93% | −2,042,251−32.8% | Reduced |
| Capital International Investors | 7,109,889 | $142.5M | 0.03% | +215,800+3.1% | Added |
| SB Management Ltd | 9,817,190 | $196.7M | 20.35% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 10,450,180 | $209.4M | 0.92% | 00.0% | Unchanged |
| Allianz Asset Management GmbH | 11,858,796 | $237.7M | 0.20% | +1,929,092+19.4% | Added |
| Capital World Investors | 19,821,407 | $397.2M | 0.07% | +6,405,970+47.8% | Added |
| Falcon Edge Capital, LP | 0 | $0 | 0.00% | −1,338,253−100.0% | Sold out |
| Laurion Capital Management LP | 0 | $0 | 0.00% | −450,000−100.0% | Sold out |
| Novo Holdings A/S | 0 | $0 | 0.00% | −422,382−100.0% | Sold out |
| Blackstone Group Inc. | 0 | $0 | 0.00% | −350,000−100.0% | Sold out |
| Cardinal Point Wealth Management LLC | 0 | $0 | 0.00% | −310,120−100.0% | Sold out |
| Hamilton Lane Advisors LLC | 0 | $0 | 0.00% | −201,381−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −174,428−100.0% | Sold out |
| Monashee Investment Management LLC | 0 | $0 | 0.00% | −135,000−100.0% | Sold out |
| Syquant Capital SAS | 0 | $0 | 0.00% | −70,000−100.0% | Sold out |
| Capstone Investment Advisors, LLC | 0 | $0 | 0.00% | −65,005−100.0% | Sold out |
| HarbourVest Partners LLC | 0 | $0 | 0.00% | −59,200−100.0% | Sold out |
| Brookfield Asset Management Inc. | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −29,972−100.0% | Sold out |
| RBF Capital, LLC | 0 | $0 | 0.00% | −23,948−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −22,900−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −19,222−100.0% | Sold out |
| Cerity Partners LLC | 0 | $0 | 0.00% | −17,000−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −15,180−100.0% | Sold out |
| Telemus Capital, LLC | 0 | $0 | 0.00% | −13,400−100.0% | Sold out |
| HAP Trading, LLC | 0 | $0 | 0.00% | −11,474−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −11,102−100.0% | Sold out |
| FORA Capital, LLC | 0 | $0 | 0.00% | −6,029−100.0% | Sold out |
| Steward Partners Investment Advisory, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −750−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −157−100.0% | Sold out |